135 related articles for article (PubMed ID: 7387799)
1. Heparin assay: a comparison between titrimetric and amidolytic methods.
Nenci GG; Berrettini M; Agnelli G; Parise P
Boll Soc Ital Biol Sper; 1980 Mar; 56(5):519-25. PubMed ID: 7387799
[TBL] [Abstract][Full Text] [Related]
2. [A method of determining heparin in blood plasma based on its antithrombin activity].
Taktashev RE; Suvorova AV; Miller VE; Kolesnikova OI
Lab Delo; 1990; (12):59-61. PubMed ID: 1710698
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a new potent heparin. 2nd communication: Chemical analysis of the carbohydrate content and determination of the biological activity of a new potent heparin preparation in vitro, using protamine neutralization and amidolytic methods for factor Xa and thrombin.
Bhargava AS; Heinick J; Günzel P
Arzneimittelforschung; 1980; 30(7):1071-4. PubMed ID: 7191289
[TBL] [Abstract][Full Text] [Related]
4. [Heparin and antiheparin in young children. 1. Report: development of a method for determining heparin and antiheparin in the antithrombin-thrombin system].
Domula M; Weissbach G
Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(5):808-23. PubMed ID: 6188669
[TBL] [Abstract][Full Text] [Related]
5. [Heparin assay in plasma. Comparison of different methods (author's transl)].
Vinazzer H
Anaesthesist; 1979 Jun; 28(6):299-303. PubMed ID: 464252
[TBL] [Abstract][Full Text] [Related]
6. Persistent spontaneous heparinaemia in systemic mastocytosis.
Nenci GG; Berrettini M; Parise P; Agnelli G
Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(3):453-63. PubMed ID: 6182065
[TBL] [Abstract][Full Text] [Related]
7. A facile colorimetric protamine titration method.
Teng CL; Yang VC
J Lab Clin Med; 1989 Apr; 113(4):498-504. PubMed ID: 2467958
[TBL] [Abstract][Full Text] [Related]
8. Monitoring unfractionated heparin therapy: relationship between eight anti-Xa assays and a protamine titration assay.
Kitchen S; Theaker J; Preston FE
Blood Coagul Fibrinolysis; 2000 Mar; 11(2):137-44. PubMed ID: 10759006
[TBL] [Abstract][Full Text] [Related]
9. Thrombin-based antithrombin assays show overestimation of antithrombin III activity in patients on heparin therapy due to heparin cofactor II influence.
Bohner J; von Pape KW; Blaurock M
Thromb Haemost; 1994 Mar; 71(3):280-3. PubMed ID: 8029789
[TBL] [Abstract][Full Text] [Related]
10. [Role of low-density lipoproteins of the blood plasma during labor in heparin neutralization].
Rółkowski R; Skrzydlewski Z; Worowski K
Zentralbl Gynakol; 1985; 107(8):491-5. PubMed ID: 4013548
[TBL] [Abstract][Full Text] [Related]
11. [Automatization of heparin determination using chronometric evaluation of anti-Xa activity of the AT III-heparin complex].
Sampol J; Rossi JM; Lejay G
Ann Biol Clin (Paris); 1984; 42(1):21-3. PubMed ID: 6731952
[TBL] [Abstract][Full Text] [Related]
12. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
Mittermayr M; Velik-Salchner C; Stalzer B; Margreiter J; Klingler A; Streif W; Fries D; Innerhofer P
Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778
[TBL] [Abstract][Full Text] [Related]
13. Relative neutralization of the biological actions of sulfaminoheparosans (K5 derivatives) and heparins by protamine sulfate.
Maddineni J; Hoppensteadt DA; Cornelli U; Manoni M; Fareed J
Clin Appl Thromb Hemost; 2007 Jan; 13(1):52-64. PubMed ID: 17164496
[TBL] [Abstract][Full Text] [Related]
14. Reliability of amidolytic assays for progressive antithrombin and heparin cofactor activities on capillary blood.
Hurlet-Birk Jensen A; Maes E; Gillet C; Legrand-Monsieur A
Thromb Haemost; 1980 Jun; 43(2):104-7. PubMed ID: 7455966
[TBL] [Abstract][Full Text] [Related]
15. [Method of determination of protamine titre].
Kriazhev LN; Timofeev GA
Lab Delo; 1978; (7):434-5. PubMed ID: 80488
[No Abstract] [Full Text] [Related]
16. [Control of heparin and oral anticoagulants, with micromethods: thrombin time, quick determination with addition of protamine].
Seiler K; Müller G; Duckert F
Schweiz Med Wochenschr; 1970 Sep; 100(36):1522-8. PubMed ID: 5524716
[No Abstract] [Full Text] [Related]
17. [Factor Xa inhibitory assay to detect plasma heparin concentrations during and after cardiopulmonary bypass].
Wang L; Li L; Shi Y; Fang Q
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Apr; 34(2):310-2. PubMed ID: 12947723
[TBL] [Abstract][Full Text] [Related]
18. Modification of an amidolytic heparin assay to express protein-bound heparin and to correct for the effect of antithrombin III concentration.
Lyon SG; Lasser EC; Stein R
Thromb Haemost; 1987 Oct; 58(3):884-7. PubMed ID: 2448889
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of a heparin removal device in comparison with protamine after hypothermic cardiopulmonary bypass.
Tao W; Deyo DJ; Brunston RL; Vertrees RA; Grochoske TL; Zwischenberger JB
ASAIO J; 1997; 43(5):M825-30. PubMed ID: 9360162
[TBL] [Abstract][Full Text] [Related]
20. The monitoring of heparin administration by screening tests in experimental dogs.
Mischke R; Jacobs C
Res Vet Sci; 2001 Apr; 70(2):101-8. PubMed ID: 11356088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
